Change in Certifying Accountants Form 8 K

Item 4.01 Changes in Registrant's Certifying Accountant

(a) On November 13, 2024, Goldenwell Biotech, Inc. (the "Company") notified Yusufali & Associates, LLC ("Yusufali & Associates") that the Company had dismissed Yusufali & Associates as the independent registered public accounting firm of the Company. The Board of Directors of the Company recommended and approved the dismissal.

The Securities and Exchange Commission has notified the Company that Public Company Accounting Oversight Board has revoked the registration Yusufali & Associates.

The reports of Yusufali & Associates regarding the Company's financial statements as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive loss, consolidated statements of changes in stockholders' equity, and consolidated statements of cash flows for the years then ended, contained no adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principle. The reports of Yusufali & Associates, however, stated that there is substantial doubt about the Company's ability to continue as a going concern.

For the years ended December 31, 2023 and 2022, and during the subsequent interim period through the date of dismissal, the Company had no disagreement with Yusufali & Associates on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of Yusufali & Associates, would have caused them to make reference thereto in their report on the Company's financial statements for such years ended December 31, 2023 and 2022, and during the subsequent interim period through the date of dismissal. There were no reportable events, as listed in Item 304(a)(1)(v) of Regulation S-K.

The Company provided Yusufali & Associates a copy of the above disclosures and requested Yusufali & Associates to furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. Yusufali & Associates's response is attached as Exhibit 16.1 to this Current Report on Form 8-K.

(b) On November 14, 2024, the board of directors of the Company resolved to engage the independent registered public accounting firm Michael Gillespie & Associates, PLLC ("Michael Gillespie & Associates"), as the Company's new independent registered public accountants, which appointment Michael Gillespie & Associates has accepted.

During the two most recent fiscal years and the interim period preceding the engagement of Michael Gillespie & Associates, the Company has not consulted with Michael Gillespie & Associates regarding either: (i) the application of accounting principles, (ii) the type of audit opinion that might be rendered by Yusufali & Associates or (iii) any other matter that was the subject of disagreement between the Company and its former auditor as described in Item 304(a)(1)(iv), or a reportable event as described in paragraph 304(a)(1)(v), of Regulation S-K. The Company did not have any disagreements with Yusufali & Associates and therefore did not discuss any past disagreements with Michael Gillespie & Associates.